Table 1 Comparison of general data between the two groups
From: Safety and efficacy of precision hepatectomy in the treatment of primary liver cancer
Indicators | Study group(49) | Control group(49) | t | P |
|---|---|---|---|---|
Age (years) | 56.29 ± 12.49 | 56.17 ± 12.56 | 0.047 | 0.963 |
Sex [M/F (n) | 29/20 | 26/23 | ||
Cirrhosis | 0.368 | 0.544 | ||
Yes | 25 | 22 | ||
No | 24 | 27 | ||
Tumor diameter (cm) | 7.65 ± 2.03 | 7.59 ± 2.01 | 0.147 | 0.881 |
Chlid-Pogh grading (n) | 0.272 | 0.602 | ||
Grade A | 39 | 41 | ||
Grade B | 10 | 8 | ||
TNM stage (n) | 0.511 | 0.475 | ||
Stage I | 36 | 39 | ||
Stage II | 13 | 10 | ||
CNLC staging (n) | 0.047 | 0.828 | ||
Stage I | 33 | 34 | ||
Stage II | 16 | 15 | ||
Pathological type (n) | 0.299 | 0.585 | ||
Hepatocellular carcinoma | 40 | 42 | ||
Bile duct cell carcinoma | 9 | 7 | ||
Cirrhosis (n) | ||||
Comorbidities (n) | ||||
Hypertension | 6 | 9 | 0.708 | 0.419 |
Stroke | 8 | 6 | 0.333 | 0.564 |
Coronary heart disease | 7 | 5 | 0.381 | 0.538 |